KIMBERLY STREIFF: Open Payments
NPI 1447504295 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,804 in 98 payments from 13 companies in 2025. Trend: 2023 $1,554 · 2024 $1,163 · 2025 $1,804
Food & beverage: $1,804
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $246 |
| Vanda Pharmaceuticals Inc. | 7 | $232 |
| Alkermes, Inc. | 15 | $228 |
| Janssen Pharmaceuticals, Inc | 6 | $221 |
| Axsome Therapeutics, Inc. | 14 | $175 |
| Lundbeck LLC | 9 | $169 |
| ABBVIE INC. | 10 | $135 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| E.R. Squibb & Sons, L.L.C. | 6 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
Products named: ARISTADA, INVEGA SUSTENNA, REXULTI, FANAPT, Auvelity, UZEDY, VRAYLAR, COBENFY.
Industry payments across PA — which companies pay providers there.
